New roles for the RB tumor supressor protein

被引:71
作者
Liu, HP [1 ]
Dibling, B [1 ]
Spike, B [1 ]
Dirlam, A [1 ]
Macleod, K [1 ]
机构
[1] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA
关键词
D O I
10.1016/j.gde.2003.11.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
For a gene whose existence was first postulated in 1971, was cloned in 1986 and whose functions have been extensively characterized ever since, you might be inclined to think there was not much new to report regarding the retinoblastoma tumor suppressor gene (RB) - but you would be wrong to make such an assumption. RIB is still piquing our interest with several activities defined over the past year that reveal new and exciting roles for this key tumor suppressor gene. These functions include regulation of senescence through specific gene silencing mechanisms, control of developmental processes in extraembryonic tissues, maintaining tissue homeostasis and determining survival responses to chemotherapy.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 102 条
  • [71] RUIZ S, COMMUNICATION
  • [72] PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells
    Ryo, A
    Liou, YC
    Wulf, G
    Nakamura, M
    Lee, SW
    Lu, KP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) : 5281 - 5295
  • [73] Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
    Sage, J
    Miller, AL
    Pérez-Mancera, PA
    Wysocki, JM
    Jacks, T
    [J]. NATURE, 2003, 424 (6945) : 223 - 228
  • [74] Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization
    Sage, J
    Mulligan, GJ
    Attardi, LD
    Miller, A
    Chen, SQ
    Williams, B
    Theodorou, E
    Jacks, T
    [J]. GENES & DEVELOPMENT, 2000, 14 (23) : 3037 - 3050
  • [75] INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
    Schmitt, CA
    McCurrach, ME
    de Stanchina, E
    Wallace-Brodeur, RR
    Lowe, SW
    [J]. GENES & DEVELOPMENT, 1999, 13 (20) : 2670 - 2677
  • [76] A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
    Schmitt, CA
    Fridman, JS
    Yang, M
    Lee, S
    Baranov, E
    Hoffman, RM
    Lowe, SW
    [J]. CELL, 2002, 109 (03) : 335 - 346
  • [77] Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth
    Sellers, WR
    Novitch, BG
    Miyake, S
    Heith, A
    Otterson, GA
    Kaye, FJ
    Lassar, AB
    Kaelin, WG
    [J]. GENES & DEVELOPMENT, 1998, 12 (01) : 95 - 106
  • [78] Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a)
    Serrano, M
    Lin, AW
    McCurrach, ME
    Beach, D
    Lowe, SW
    [J]. CELL, 1997, 88 (05) : 593 - 602
  • [79] Shackney SE, 1997, CYTOMETRY, V29, P1
  • [80] The RB and p53 pathways in cancer
    Sherr, CJ
    McCormick, F
    [J]. CANCER CELL, 2002, 2 (02) : 103 - 112